CIPLA - Cipla Limited
NSE
->
Healthcare
->
Drug Manufacturers—General
Mumbai,
India
Type: Equity
CIPLA price evolution
CIPLA
| (in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $18345.8 | $19284.8 | ||
| Short term investments | $23509.4 | $21949.7 | ||
| Net receivables | $39738 | $34280.1 | ||
| Inventory | $54409.9 | $53502.4 | ||
| Total current assets | $159058.3 | $147108.3 | ||
| Long term investments | $5455 | $3556.3 | ||
| Property, plant & equipment | $56506.2 | $56087.2 | ||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $280628.2 | $271011.2 | ||
| Current liabilities | ||||
| Accounts payable | $24007.7 | $25081 | ||
| Deferred revenue | ||||
| Short long term debt | $8406.7 | $4079 | ||
| Total current liabilities | $53092 | $49132.1 | ||
| Long term debt | $120.4 | $4162.4 | ||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $58934.5 | $59837.4 | ||
| Shareholders' equity | ||||
| Retained earnings | $188138.7 | |||
| Other shareholder equity | $217228.8 | $206803.3 | ||
| Total shareholder equity | $218842.8 | $208416.9 | $208416.9 | $194322.3 |
| (in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $19284.8 | $7932.9 | $7423.8 | $5083.6 |
| Short term investments | $21949.7 | $6703.6 | $2500.8 | $1008.1 |
| Net receivables | $34280.1 | $36193.4 | $42260.7 | $43988.2 |
| Inventory | $53502.4 | $46691.8 | $43776 | $39648.3 |
| Total current assets | $147108.3 | $131810.3 | $117038.4 | $124266.3 |
| Long term investments | $3556.3 | $4236.8 | $4545 | $4785.7 |
| Property, plant & equipment | $56087.2 | $56488.6 | $56733.5 | $55072.5 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $271011.2 | $251518.9 | $236625.6 | $239633.2 |
| Current liabilities | ||||
| Accounts payable | $25081 | $20668.2 | $22818.1 | $19479.9 |
| Deferred revenue | ||||
| Short long term debt | $4079 | $2277.8 | $167.5 | |
| Total current liabilities | $49132.1 | $45915.5 | $43931.4 | $37715.1 |
| Long term debt | $4162.4 | $12027.5 | $23692.8 | $38300.7 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $59837.4 | $65663 | $76052.8 | $86190.7 |
| Shareholders' equity | ||||
| Retained earnings | $188138.7 | $166816.2 | $142605 | $133939.3 |
| Other shareholder equity | $206803.3 | -$1296.9 | -$2607.8 | -$1173.8 |
| Total shareholder equity | $208416.9 | $183265.3 | $157630 | $150122.8 |
| (in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $58285.4 | $53751.9 | $52603.3 | $54788.6 |
| Cost of revenue | $21601.8 | $20244.3 | $21467 | $21433.7 |
| Gross Profit | $36683.6 | $33507.6 | $31136.3 | $33354.9 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $9608.1 | $9557.4 | $8924.1 | $8724.3 |
| Total operating expenses | $48255.8 | $44862.5 | $48009.2 | $44953.6 |
| Operating income | $10029.6 | $8889.4 | $4594.1 | $9835 |
| Income from continuing operations | ||||
| EBIT | $10029.6 | $8889.4 | $4594.1 | $9835 |
| Income tax expense | $3026 | $2680 | $711.1 | $2951.6 |
| Interest expense | -$255.5 | -$178.1 | -$181 | -$206.8 |
| Net income | ||||
| Net income | $7889 | $6864 | $3620.7 | $7286 |
| Income (for common shares) | $7889 | $6864 | $3620.7 | $7286 |
| (in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $217633.4 | $191219 | $170805.3 | $163232.3 |
| Cost of revenue | $84956 | $75063.7 | $61480.4 | $59285.2 |
| Gross Profit | $132677.4 | $116155.3 | $109324.9 | $103947.1 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $35299.1 | $41281.2 | $38693.7 | $37415.4 |
| Total operating expenses | $182625.1 | $158563.9 | $149605.5 | $142819.7 |
| Operating income | $35008.3 | $32655.1 | $21199.8 | $20412.6 |
| Income from continuing operations | ||||
| EBIT | $35008.3 | $32655.1 | $21199.8 | $20412.6 |
| Income tax expense | $9338 | $8887.6 | $6312 | $5695.3 |
| Interest expense | -$1063.5 | -$1529.8 | -$1892.3 | -$1637.7 |
| Net income | ||||
| Net income | $25167.5 | $24048.7 | $15465.2 | $15277 |
| Income (for common shares) | $25167.5 | $24048.7 | $15465.2 | $15277 |
| (in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Net income | $7889 | $6864 | $3620.7 | $7286 |
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | ||||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | ||||
| Effect of exchange rate | ||||
| Change in cash and equivalents | ||||
| (in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
|---|---|---|---|---|
| Net income | $25167.5 | $24048.7 | $15465.2 | $15277 |
| Operating activities | ||||
| Depreciation | $10519.5 | $9638.1 | $10564 | $10565.1 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $33259 | $37552 | $30684.5 | $16911.4 |
| Investing activities | ||||
| Capital expenditures | -$5441.1 | -$6296.6 | -$5727.7 | -$3600.8 |
| Investments | $1525.7 | -$12586.3 | $11766.9 | -$10683.7 |
| Total cash flows from investing | -$18718.8 | -$23871.8 | $1040.4 | -$16686.8 |
| Financing activities | ||||
| Dividends paid | -$4033.5 | -$2417.7 | -$2415.7 | |
| Sale and purchase of stock | ||||
| Net borrowings | -$10983.3 | -$11678.5 | -$17600.2 | -$602.5 |
| Total cash flows from financing | -$15997.9 | -$13299 | -$29488.2 | -$3487.2 |
| Effect of exchange rate | $134.5 | $127.9 | $103.5 | -$188.5 |
| Change in cash and equivalents | -$1323.2 | $509.1 | $2340.2 | -$3451 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $219.43B |
|---|---|
| EBITDA | N/A |
| EBIT | $33.35B |
| Net Income | $25.66B |
| Revenue Q/Q | 5.59% |
| Revenue Y/Y | 5.69% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | 12.37% |
| Debt/Equity | 0.29 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 3.00 |
| Quick ratio | 1.97 |